Expression of mutant ??-synucleins enhances dopamine transporter-mediated MPP+ toxicity in vitro
Authors:
- Eva-Maria TanETEva-Maria Tan
- Johannes SchwarzJSJohannes Schwarz
- Alexander StorchASAlexander Storch
- 1 July 2002
- journal article
- Published by Wolters Kluwer Health in NeuroReport
- Vol. 13 (10) , 1279-1283
Abstract
Mutations in the α-synuclein gene (A30P and A53T) are reported to cause familial Parkinson's disease (PD), but it is not known how they result in selective dopaminergic cell death. Here we report on effects of mutant α-synucleins on dopamine transporter (DAT)-mediated toxicity of the selective dopaminergic neurotoxin 1-methyl-4-phenylpyridinium ion (MPP+) in vitro. We established human embryonic kidney HEK-293 cell lines stably co-expressing each α-synuclein isoform and the human DAT. We demonstrate that expression of all α-synuclein isoforms enhances toxicity of general complex I inhibition (rotenone), but only the expression of mutant α-synucleins induces significant increased DAT-dependent toxicity of very low concentrations of MPP+ compared to wild-type protein. Proteasomal inhibition by lactacystin does not alter MPP+-toxicity in all cell lines. Our data suggest a new mechanism of MPP+-induced dopaminergic toxicity by an interaction between mutant α-synucleins and the DAT, which is independent of the function of the proteasome.Keywords
This publication has 18 references indexed in Scilit:
- Alpha-synuclein and neurodegenerative diseasesNature Reviews Neuroscience, 2001
- Effect of the overexpression of wild‐type or mutant α‐synuclein on cell susceptibility to insultJournal of Neurochemistry, 2001
- Chronic systemic pesticide exposure reproduces features of Parkinson's diseaseNature Neuroscience, 2000
- Expression of mutant alpha-synuclein causes increased susceptibility to dopamine toxicityHuman Molecular Genetics, 2000
- Effects of the mutations Ala30 to Pro and Ala53 to Thr on the physical and morphological properties of α‐synuclein protein implicated in Parkinson's diseaseFEBS Letters, 1998
- Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson diseaseNature Medicine, 1998
- The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and diseaseTrends in Neurosciences, 1998
- Hypothesis: The role of dopaminergic transporters in selective vulnerability of cells in Parkinson's diseaseAnnals of Neurology, 1998
- α-Synuclein in Lewy bodiesNature, 1997
- Mutation in the α-Synuclein Gene Identified in Families with Parkinson's DiseaseScience, 1997